Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.

TitleGynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.
Publication TypeJournal Article
Year of Publication2014
AuthorsLeitao, MM, Cheng, X, Hamilton, AL, Siddiqui, NAhmad, Jürgenliemk-Schulz, IM, Mahner, S, Åvall-Lundqvist, E, Kim, K, Freyer, G
JournalInt J Gynecol Cancer
Volume24
Issue9 Suppl 3
PaginationS117-22
Date Published11/2014
ISSN1525-1438
KeywordsCombined Modality Therapy, Consensus, Female, Humans, Medical Oncology, Melanoma, Practice Guidelines as Topic, Societies, Medical, Vaginal Neoplasms, Vulvar Neoplasms
Abstract

Vulvovaginal melanomas are rare tumors that account for a small fraction of all vulvovaginal cancers. Biologically, they seem to be similar to mucosal and acral melanomas of other sites. There are limited data specific to vulvovaginal melanomas, especially regarding systemic therapies. Most treatment decisions are based on extrapolation from data regarding cutaneous melanomas of other sites. It is reasonable to follow already established guidelines from other professional groups and societies. Outcomes tend to be worse compared with cutaneous melanomas likely because of the later presentation and physical biological characteristics of these tumors.

DOI10.1097/IGC.0000000000000198
Alternate JournalInt. J. Gynecol. Cancer
PubMed ID24987924